Digital Biomanufacturing Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

Which drivers are expected to have the greatest impact on the over the digital biomanufacturing market's growth?
The surge in the need for biologics is predicted to be a significant driver for the expansion of the digital biomanufacturing market. Biologics refer to a broad spectrum of pharmaceuticals, inclusive of vaccines, growth factors, immunological modulators, monoclonal antibodies, as well as medications developed from human blood and plasma. Utilizing digital biomanufacturing allows for the improvement of biologic production by streamlining processes, enhancing quality control, reducing expenditures, and curtailing production time. This enables producers to adopt data-centric strategies and advanced technologies to adequately, and more environmentally responsibly, meet the escalating demand for biologics. In February 2023, for instance, Cell & Gene, a US-based digital platform for researchers, reported that of the 340 approved biologics in 2022, 27 were FDA-approved cell and gene therapies (CGTs), constituting approximately 8%. This demonstrates an increase from 22 approvals in 2021. Consequently, the escalating demand for biologics is catalysing the growth of the digital biomanufacturing market.

Get Your Digital Biomanufacturing Market Report Here:
https://www.thebusinessresearchcompany.com/report/digital-biomanufacturing-global-market-report

What is the future CAGR of the digital biomanufacturing market, and how will it impact industry expansion?
There has been swift growth in the digital biomanufacturing market in recent times. This market, valued at $21.11 billion in 2024, is projected to expand to $23.82 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 12.8%. A rise in the intricacy of biopharmaceuticals, a spike in personalized medicine, a need for affordable manufacturing, optimization of bioprocess, and maintaining high standards of quality control and regulatory compliance have all contributed to growth during the historic period.

The market size of digital biomanufacturing is projected to experience substantial growth in the upcoming years, swelling to a value of $40.43 billion in 2029 with a compound annual growth rate (CAGR) of 14.1%. This anticipated expansion during the forecast period can be attributed to several factors including blockchain implementation for supply chain transparency, the deployment of advanced process control (APC) systems, a focus on sustainability, integration of interconnected biomanufacturing systems, and biomanufacturing in emerging markets. Concurrent trends that will be prominent during this projected timeframe encompass the incorporation of artificial intelligence (AI), employing digital twins for bioprocessing, advancements in biotechnology, integration of Industry 4.0, and real-time monitoring and controlling.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10828&type=smp

What are the most significant trends transforming the digital biomanufacturing market today?
Leading companies within the market are concentrating on pioneering solutions like single-use bioprocessing systems to maintain their market standing. These systems augment digital biomanufacturing by offering flexibility, real-time observations, lowering contamination threats, and providing cost-effectiveness. For example, in October 2022, an India-based biotech startup, PharmNXT Biotech LLP, inaugurated its first integrated manufacturing operation in Pune for offering single-use bioprocessing solutions. This sophisticated facility was established to tackle the myriad challenges associated with biologics production in India. The novel establishment will create jobs for between 100 and 200 individuals, satisfying demand emanating from international markets such as Singapore, Korea, Europe, and the US. Furthermore, the manufacturing site will engage in the production of the Xelta line of single-use bioprocessing merchandise and the 'NXTmix' levitating mixing technology.

Which key market segments comprise the digital biomanufacturing market and drive its revenue growth?
The digital biomanufacturing market covered in this report is segmented -

1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes

Subsegments:
1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies
2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools
3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software
4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For Biomanufacturing

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10828

What regions are at the forefront of digital biomanufacturing market expansion?
North America was the largest region in the digital biomanufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the digital biomanufacturing market?
Major companies operating in the digital biomanufacturing market include Sanofi SA, Thermo Fisher Scientific Inc., Honeywell International Inc., 3M Company, SAP SE, Danaher Corporation, ABB AG, Siemens Healthineers AG, Emerson Electric Co, GE HealthCare Technologies Inc., Atos SE, Agilent Technologies Inc., Cytiva Europe GmbH, Lonza Group AG, Dassault Systèmes SE, Sartorius AG, BioMérieux, Donaldson Company Inc., Pall Corporation, Eppendorf AG, Symphony Innovation LLC, Koch Membrane Systems Inc., Culture Biosciences Inc., Bota Biosciences Inc., Shimadzu Corporation, e-MSion, Exponential Genomics Inc., Immersciobio GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=10828&type=smp

What Is Covered In The Digital Biomanufacturing Global Market Report?

•Market Size Forecast: Examine the digital biomanufacturing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the digital biomanufacturing market for a structured understanding.
•Key Players Overview: Analyze major players in the digital biomanufacturing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the digital biomanufacturing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the digital biomanufacturing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the digital biomanufacturing market.
•Industry Challenges: Identify potential risks and obstacles affecting the digital biomanufacturing market.
•Competitive Landscape: Review strategic developments in the digital biomanufacturing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.